Comparison of Outcomes Between Low Dose Emicizumab and Factor VIII in Clinically Severe Hemophilia A
Clinical trial NCT06155955 · UNKNOWN
Trial details
- NCT number
- NCT06155955
- Sponsor
- Chulalongkorn University
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-22
- Primary completion
- 2024-03-21
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.